4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0002021238-26-000006
Chief Discovery Officer sold 3,316 shares at $26.61 ($88,239)
From the SEC's structured data for this filing
Trades in this filing
Kreitzer Anatol · Chief Discovery Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-15 | Sale : show line 1 in the form | −3,316 | $26.61 | $88,239 | 256,612 | D |
| Open-market sales · 3,316 sh · avg $26.61 · $88,239 | ||||||
Loading xslF345X06/form4-04172026_040415.xml…